Genus (FRA:GBE) Beginning Cash Position : €42.1 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Genus Beginning Cash Position?

Genus's Beginning Cash Position for the quarter that ended in Dec. 2023 was €42.1 Mil.

Genus's quarterly Beginning Cash Position increased from Dec. 2022 (€44.6 Mil) to Jun. 2023 (€49.3 Mil) but then declined from Jun. 2023 (€49.3 Mil) to Dec. 2023 (€42.1 Mil).

Genus's annual Beginning Cash Position increased from Jun. 2021 (€48.1 Mil) to Jun. 2022 (€53.6 Mil) but then declined from Jun. 2022 (€53.6 Mil) to Jun. 2023 (€45.2 Mil).

Genus Beginning Cash Position Historical Data

The historical data trend for Genus's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Beginning Cash Position Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

32.64

33.90

48.08

53.59

45.22

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															54.14	53.47	44.61	49.30	42.14

Genus Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Genus Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Genus's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (FRA:GBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GNS:UK

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (FRA:GBE) Headlines

No Headlines